PSNL vs. AHCO, VRDN, CDNA, AVAH, GRAL, FTRE, PNTG, CSTL, FLGT, and AUNA
Should you be buying Personalis stock or one of its competitors? The main competitors of Personalis include AdaptHealth (AHCO), Viridian Therapeutics (VRDN), CareDx (CDNA), Aveanna Healthcare (AVAH), Grail (GRAL), Fortrea (FTRE), The Pennant Group (PNTG), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), and Auna (AUNA). These companies are all part of the "healthcare" industry.
Personalis vs.
Personalis (NASDAQ:PSNL) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.
AdaptHealth has a net margin of -6.57% compared to Personalis' net margin of -104.52%. AdaptHealth's return on equity of 9.62% beat Personalis' return on equity.
Personalis received 36 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 68.13% of users gave Personalis an outperform vote while only 62.41% of users gave AdaptHealth an outperform vote.
Personalis currently has a consensus price target of $7.80, indicating a potential upside of 103.13%. AdaptHealth has a consensus price target of $13.80, indicating a potential upside of 32.82%. Given Personalis' higher possible upside, analysts plainly believe Personalis is more favorable than AdaptHealth.
Personalis has higher earnings, but lower revenue than AdaptHealth. Personalis is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
Personalis has a beta of 1.73, suggesting that its stock price is 73% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500.
In the previous week, AdaptHealth had 1 more articles in the media than Personalis. MarketBeat recorded 6 mentions for AdaptHealth and 5 mentions for Personalis. AdaptHealth's average media sentiment score of 1.40 beat Personalis' score of 0.14 indicating that AdaptHealth is being referred to more favorably in the news media.
61.9% of Personalis shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 4.1% of Personalis shares are held by insiders. Comparatively, 4.4% of AdaptHealth shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
AdaptHealth beats Personalis on 9 of the 16 factors compared between the two stocks.
Get Personalis News Delivered to You Automatically
Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Personalis Competitors List
Related Companies and Tools
This page (NASDAQ:PSNL) was last updated on 3/24/2025 by MarketBeat.com Staff
